Salmeterol
A long-acting bronchodilator for asthma and COPD management.
Salmeterol is a long-acting β2 adrenergic receptor agonist (LABA) used in the treatment and prevention of asthma symptoms and control of chronic obstructive pulmonary disease (COPD) symptoms.
- medical use began
- 1990
- brand name (US)
- Serevent
- drug class
- long-acting β2 adrenergic receptor agonist (LABA)
- duration of action
- approximately 12 hours
- common combination
- fluticasone/salmeterol (Advair in US, Seretide in UK)
Lore & Background
Salmeterol was first marketed and manufactured by Glaxo (now GlaxoSmithKline) in the 1980s and released as Serevent in 1990. It is a long-acting β2 adrenergic receptor agonist that stimulates beta-2 receptors in bronchial musculature, causing relaxation and preventing asthma symptoms. Its high lipophilicity allows it to dissolve in the cell membrane and provide extended action, lasting about 12 hours compared to 4–6 hours for short-acting beta agonists like salbutamol.
Reader's Guide
Salmeterol is significant as a cornerstone of moderate-to-severe persistent asthma and COPD management, offering prolonged bronchodilation. Its development marked a shift from short-acting to long-acting control, improving daily symptom prevention and reducing asthma attack frequency when used with inhaled corticosteroids. This has led to strict guidelines that LABAs should not be used as monotherapy in asthma but only with inhaled corticosteroids. In COPD, monotherapy or combination use is acceptable. The drug's mechanism—high lipophilicity enabling gradual release from cell membranes—explains its extended duration but also its slower onset compared to formoterol. Salmeterol remains widely used, often in fixed-dose combinations like fluticasone/salmeterol, balancing efficacy with ongoing risk monitoring.
Did You Know?
- A 12 μg dose of formoterol is equivalent to a 50 μg dose of salmeterol.
- The Torch study showed benefits in quality of life and lung function for salmeterol alone or with inhaled corticosteroids in COPD patients.
Frequently Asked Questions
What are Salmeterol's powers and role?
By stimulating β2 receptors in the smooth muscle lining the lungs, Salmeterol relaxes that muscle and keeps the bronchi dilated for roughly 12 hours per dose. It is prescribed both to prevent asthma symptoms and to manage the day-to-day burden of COPD.
Why is Salmeterol important in pharmacology?
As one of the earliest widely adopted LABAs, Salmeterol reshaped daily respiratory care by giving patients a single dose that covers a full 12-hour period. Its pairing with fluticasone produced the combination inhalers sold as Advair in the US and Seretide in the UK, which remain cornerstones of asthma and COPD therapy.
More in Medications And Pharmacology 1-20
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record